Kandu, Inc. Announces $30 Million Financing to Advance Stroke Recovery and Rehabilitation VAN NUYS, Calif.--(BUSINESS WIRE)--KanduTM Health, Inc. and Neurolutions,…
Burlington, Ontario--(Newsfile Corp. - April 8, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotech…
PHOENIX, April 08, 2025 (GLOBE NEWSWIRE) -- The healthcare industry has outgrown the outdated and rigid model of Reference-Based Pricing.…
New partnership strengthens Psyence BioMed's global clinical trial capabilities, accelerating the development of psilocybin-assisted therapy for adjustment disorderNew York, New…
Strategic alliance set to strengthen supply chains for medical isotopes, industrial applications, and fusion technologies between North America and Asia,…
Xeltis is one of only seven companies to successfully pass evaluation phase of EIC Strategic Technologies for Europe Platform (STEP)…
The partnership integrates advanced AI-driven analytics and clinical trial solutions, empowering biopharma companies to accelerate drug development and deliver targeted…
Emerging biotechnology is key for U.S. to remain dominant and secure future economic growth in a new era of global…
Montreal, Quebec--(Newsfile Corp. - April 8, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"),…
NEW YORK & VALENCIA, Spain & CAMBRIDGE, England--(BUSINESS WIRE)--#AIinHealthcare--Quibim, the global pioneer in imaging biomarkers for precision medicine, is pleased…